Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.
Clinical trial NCT03388593 · UNKNOWN
Trial details
- NCT number
- NCT03388593
- Sponsor
- Zensun Sci. & Tech. Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-23
- Primary completion
- 2026-02-01
- Enrollment
- 1600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.